...
SDPA Fall 2018 | Product Theater | Are Your Topical Patients Systemic-Ready? An Oral Treatment Option for Moderate to Severe Plaque Psoriasis
November 3, 2018

At the first product theater on day 3 of the 16th Annual Fall Dermatology Conference, Dr. Firas Hougeir shared his extensive knowledge and experience in the treatment of patients with psoriasis with his lecture entitled Are Your Topical Patients Systemic-Ready? An Oral Treatment Option for Moderate to Severe Plaque Psoriasis. Dr. Hougeir started his lecture …

...
Summer 2018 | Live Blog | Product Theater | Are Your Topical Patients Systemic Ready? An Oral Treatment Option for Moderate to Severe Plaque Psoriasis
June 29, 2018

The second product theater on day 2 of the SDPA Annual Summer Conference presented by Robert Casquejo, PA-C discussed Otezla as a treatment for adult patients with active psoriatic arthritis and patients with moderate to severe plaque psoriasis who are candidates for phototherapy and systemic therapy. Otezla is an oral medication that inhibits phosphodiesterase 4 …